These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 17002866

  • 1. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
    Shibuya M.
    J Biochem Mol Biol; 2006 Sep 30; 39(5):469-78. PubMed ID: 17002866
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.
    Shibuya M.
    Endothelium; 2006 Sep 30; 13(2):63-9. PubMed ID: 16728325
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.
    Shibuya M.
    J Biochem; 2013 Jan 30; 153(1):13-9. PubMed ID: 23172303
    [Abstract] [Full Text] [Related]

  • 6. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
    Hiratsuka S, Nakao K, Nakamura K, Katsuki M, Maru Y, Shibuya M.
    Mol Cell Biol; 2005 Jan 30; 25(1):346-54. PubMed ID: 15601855
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S, Bayle M, Laïn G, Déléris G.
    Curr Med Chem Anticancer Agents; 2003 Mar 30; 3(2):95-117. PubMed ID: 12678905
    [Abstract] [Full Text] [Related]

  • 8. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nör JE.
    Cell Death Differ; 2010 Mar 30; 17(3):499-512. PubMed ID: 19834490
    [Abstract] [Full Text] [Related]

  • 9. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G, Clauss M, Risau W.
    Dev Dyn; 1995 Nov 30; 204(3):228-39. PubMed ID: 8573716
    [Abstract] [Full Text] [Related]

  • 10. VEGFR1 and VEGFR2 in Alzheimer's Disease.
    Harris R, Miners JS, Allen S, Love S.
    J Alzheimers Dis; 2018 Nov 30; 61(2):741-752. PubMed ID: 29226875
    [Abstract] [Full Text] [Related]

  • 11. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
    Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP.
    FASEB J; 2006 Jul 30; 20(9):1495-7. PubMed ID: 16754748
    [Abstract] [Full Text] [Related]

  • 12. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A, Mansouri K, Alemzadeh G, Safa M, Rastaghi AE, Asghari SM.
    Biochim Biophys Acta Gen Subj; 2018 Dec 30; 1862(12):2688-2700. PubMed ID: 30251659
    [Abstract] [Full Text] [Related]

  • 13. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R, Hemanthakumar KA, Vaparanta K, Robciuc M, Izumiya Y, Kidoya H, Takakura N, Peng X, Sawyer DB, Elenius K, Walsh K, Alitalo K.
    Circulation; 2019 May 28; 139(22):2570-2584. PubMed ID: 30922063
    [Abstract] [Full Text] [Related]

  • 14. Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2.
    Thalgott JH, Dos-Santos-Luis D, Hosman AE, Martin S, Lamandé N, Bracquart D, Srun S, Galaris G, de Boer HC, Tual-Chalot S, Kroon S, Arthur HM, Cao Y, Snijder RJ, Disch F, Mager JJ, Rabelink TJ, Mummery CL, Raymond K, Lebrin F.
    Circulation; 2018 Dec 04; 138(23):2698-2712. PubMed ID: 30571259
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
    Sadremomtaz A, Kobarfard F, Mansouri K, Mirzanejad L, Asghari SM.
    J Recept Signal Transduct Res; 2018 Dec 04; 38(5-6):432-441. PubMed ID: 30929546
    [Abstract] [Full Text] [Related]

  • 17. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.
    Zachary I, Gliki G.
    Cardiovasc Res; 2001 Feb 16; 49(3):568-81. PubMed ID: 11166270
    [Abstract] [Full Text] [Related]

  • 18. [Non-angiogenic functions of vascular endothelial growth factor].
    Xiong Y, Han XF, Luo JC.
    Sheng Li Ke Xue Jin Zhan; 2011 Feb 16; 42(1):6-10. PubMed ID: 21595180
    [Abstract] [Full Text] [Related]

  • 19. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, Persson JL.
    Anticancer Res; 2013 Jun 16; 33(6):2381-90. PubMed ID: 23749886
    [Abstract] [Full Text] [Related]

  • 20. A chemically defined culture of VEGFR2+ cells derived from embryonic stem cells reveals the role of VEGFR1 in tuning the threshold for VEGF in developing endothelial cells.
    Hirashima M, Ogawa M, Nishikawa S, Matsumura K, Kawasaki K, Shibuya M, Nishikawa S.
    Blood; 2003 Mar 15; 101(6):2261-7. PubMed ID: 12406893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.